Clinical trial
A Randomized Phase 2 Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5)
NCT03975114 is registered in ClinicalTrials.gov with National Cancer Institute, Naples as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase 2 Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5)
- Lead sponsor
- National Cancer Institute, Naples
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 20, 2018
- Completion date
- June 30, 2024
- Enrollment
- 460 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.